title: Comment on Balestrieri et al. Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment. Diabetes 2015;64:1395-1406.
authors.affiliation: Department of Intensive Care Unit, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
authors.forename: Wei-Li
authors.initials: WL
authors.lastname: Yu
authors.affiliation: Department of Intensive Care Unit, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China sunyun15@163.com.
authors.forename: Yun
authors.initials: Y
authors.lastname: Sun
mesh_terms: D002339:Carotid Arteries / Q000187:drug effects*; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000494:pharmacology*; D005260:Female; D006801:Humans; D054795:Incretins / Q000494:pharmacology*; D008297:Male; D058226:Plaque, Atherosclerotic / Q000378:metabolism*; D018027:Receptors, Glucagon / Q000819:agonists*; D037761:Sirtuins / Q000378:metabolism*
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D054795:Incretins; D018027:Receptors, Glucagon; D037761:Sirtuins